Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT05781893
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with PCC will be included. PCC will be defined as:
* History of confirmed or suspected SARS CoV-2 infection
* Symptoms usually start within 3 months from the onset of acute SARS CoV-2 infection with symptoms and effects that last for at least 2 months
* Symptoms cannot be explained by an alternative diagnosis
* signed informed consent is required
Additional Inclusion Criteria for participtation in DiLCoS:
* A smartphone with a compartible-operating system
* Separate signed informed consent is required
Exclusion Criteria:
* Age \<18 years
* Lack of consent to participate in the study
* Language barriers (lack of sufficient knowledge of German)
* Lack of general understanding of study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05781893
Study Brief:
Protocol Section:
NCT05781893